The Common Hallmarks of Aging, Circadian Rhythms and Cancer: Implications for Therapeutic Strategies
Research,
Journal Year:
2025,
Volume and Issue:
8
Published: Jan. 1, 2025
The
intricate
relationship
between
cancer,
circadian
rhythms,
and
aging
is
increasingly
recognized
as
a
critical
factor
in
understanding
the
mechanisms
underlying
tumorigenesis
cancer
progression.
Aging
well-established
primary
risk
for
while
disruptions
rhythms
are
intricately
associated
with
progression
of
various
tumors.
Moreover,
itself
disrupts
leading
to
physiological
changes
that
may
accelerate
development.
Despite
these
connections,
specific
interplay
processes
their
collective
impact
on
remains
inadequately
explored
literature.
In
this
review,
we
systematically
explore
influence
We
discuss
how
core
genes
tumor
prognosis,
highlighting
shared
hallmarks
such
genomic
instability,
cellular
senescence,
chronic
inflammation.
Furthermore,
examine
aging,
focusing
crosstalk
contributes
tumorigenesis,
proliferation,
apoptosis,
well
metabolism
stability.
By
elucidating
common
pathways
linking
review
provides
new
insights
into
pathophysiology
identifies
potential
therapeutic
strategies.
propose
targeting
regulation
could
pave
way
novel
treatments,
including
chronotherapy
antiaging
interventions,
which
offer
important
benefits
clinical
management
cancer.
Language: Английский
The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways
Dengxiong Li,
No information about this author
Fanglin Shao,
No information about this author
Qingxin Yu
No information about this author
et al.
Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Aug. 19, 2024
Drug
resistance
remains
a
significant
challenge
in
cancer
treatment.
Recently,
the
interactions
among
various
cell
types
within
tumor
microenvironment
(TME)
have
deepened
our
understanding
of
mechanisms
behind
treatment
resistance.
Therefore,
this
review
aims
to
synthesize
current
research
focusing
on
infiltrating
cells
and
drug
suggesting
that
targeting
TME
could
be
viable
strategy
combat
issue.
Numerous
factors,
including
inflammation,
metabolism,
senescence,
hypoxia,
angiogenesis,
contribute
Overexpression
STAT3
is
commonly
associated
with
drug-resistant
or
stromal
cells.
Current
often
generalizes
impact
resistance,
lacking
specificity
statistical
robustness.
Thus,
future
should
take
notice
issue
aim
provide
high-quality
evidence.
Despite
existing
limitations,
overcome
therapy
hold
promising
valuable
potential.
Language: Английский
Circadian rhythms and breast cancer: unraveling the biological clock’s role in tumor microenvironment and ageing
Yalan Yan,
No information about this author
Lanqian Su,
No information about this author
Shanshan Huang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 30, 2024
Breast
cancer
(BC)
is
one
of
the
most
common
and
fatal
malignancies
among
women
worldwide.
Circadian
rhythms
have
emerged
in
recent
studies
as
being
involved
pathogenesis
breast
cancer.
In
this
paper,
we
reviewed
molecular
mechanisms
by
which
dysregulation
circadian
genes
impacts
development
BC,
focusing
on
critical
clock
genes,
brain
muscle
ARNT-like
protein
1
(BMAL1)
locomotor
output
cycles
kaput
(CLOCK).
We
discussed
how
rhythm
disruption
(CRD)
changes
tumor
microenvironment
(TME),
immune
responses,
inflammation,
angiogenesis.
The
CRD
compromises
surveillance
features
activities
effectors,
including
CD8+
T
cells
tumor-associated
macrophages,
that
are
important
an
effective
anti-tumor
response.
Meanwhile,
review,
discuss
bidirectional
interactions:
age
rhythms,
aging
further
increases
risk
through
reduced
vasoactive
intestinal
polypeptide
(VIP),
affecting
suprachiasmatic
nucleus
(SCN)
synchronization,
ability
to
repair
damaged
DNA,
weakened
immunity.
These
complex
interplays
open
new
avenues
toward
targeted
therapies
combination
drugs
with
chronotherapy
potentiate
response
while
reducing
progression
for
better
outcomes.
This
review
tries
cover
broad
area
emerging
knowledge
tumor-immune
nexus
affected
Language: Английский
Advancements and Challenges of R-loops in Cancers: Biological Insights and Future Directions
Cancer Letters,
Journal Year:
2024,
Volume and Issue:
610, P. 217359 - 217359
Published: Nov. 27, 2024
Language: Английский
Interactions Between Radiotherapy Resistance Mechanisms and the Tumor Microenvironment
Critical Reviews in Oncology/Hematology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 104705 - 104705
Published: March 1, 2025
Language: Английский
Decoding the crossroads of aging and cancer through single‐cell analysis: Implications for precision oncology
Dengxiong Li,
No information about this author
Qingxin Yu,
No information about this author
Fanglin Shao
No information about this author
et al.
International Journal of Cancer,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 23, 2025
Abstract
Single‐cell
analysis
is
a
transformative
approach
to
understanding
cellular
heterogeneity
in
aging
and
cancer,
interconnected
processes
driven
by
mechanisms
like
senescence
immune
modulation.
This
review
explores
how
influences
cancer
initiation,
progression,
treatment
resistance
within
the
tumor
microenvironment
(TME).
By
examining
recent
studies
using
single‐cell
technologies,
we
reveal
nuanced
roles
of
tumorigenesis,
interactions,
therapeutic
outcomes.
Aging
closely
tied
with
senescent
cells
demonstrating
heightened
proliferative,
invasive,
metastatic
capabilities.
Emerging
senolytic
therapies
targeting
aging‐related
pathways
hold
promise
for
enhancing
efficacy.
Advanced
tools
such
as
spatial
transcriptomics,
molecular
probes,
artificial
intelligence
further
refine
our
TME.
integrating
these
future
research
can
clarify
intricate
interactions
between
advancing
precision
oncology
improving
outcomes
patients.
Language: Английский
Identification of circadian clock-related immunological prognostic index and molecular subtypes in prostate cancer
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Sept. 11, 2024
Language: Английский
Exploring the role of ADAMTSL2 across multiple cancer types: A pan-cancer analysis and validated in colorectal cancer
Qing-xin Yu,
No information about this author
Ruicheng Wu,
No information about this author
Jie Wang
No information about this author
et al.
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Oct. 9, 2024
Recent
studies
have
established
a
correlation
between
ADAMTSL2
(ADAMTS-like
2)
and
the
development
of
various
cancers.
This
study
aims
to
conduct
comprehensive
pan-cancer
analysis
in
37
cancer
types
investigate
its
potential
role
colon
rectal
adenocarcinoma
(COADREAD).
Language: Английский